News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

The Scripps Research Institute Scientists Design a Potential Drug Compound that Attacks Parkinson’s Disease on Two Fronts


6/21/2013 7:50:38 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have found a compound that could counter Parkinson’s disease in two ways at once. In a new study published recently online ahead of print by the journal ACS Chemical Biology, the scientists describe a “dual inhibitor”—two compounds in a single molecule—that attacks a pair of proteins closely associated with development of Parkinson’s disease.

Hey, check out all the research scientist jobs. Post your resume today!


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES